Prospective Multicenter Study Shows Remarkable Healing Rates with Sonendo’s GentleWave® System

LAGUNA HILLS, Calif., July 25, 2016 (GLOBE NEWSWIRE) -- Sonendo®, Inc., — The developer of a breakthrough technology that offers an alternative to conventional root canal therapy, today announced that clinical results using their GentleWave® System have been reported in the current print and online issues of the Journal of Endodontics. The study can be found online at

The work was led by Prof., Asgeir Sigurdsson, cand, Odont., DDS, MS, Cert End (UNC), Chairman of Endodontics, University of New York College of Dentistry. Prof., Asgeir Sigurdsson stated, “This study strongly indicates that the GentleWave System does what it was intended to do; it cleans and disinfects the root canal space in a predictable and consistent way resulting in periapical healing rates that are extremely high in this study. Most importantly, though, is the fact that the System does this automatically and with maximal preservation of tooth and root structure.”

Chris Rabbitt, Chief Commercial Officer of Sonendo, stated, “We applaud the investigators in this study for their rigor in examining how the GentleWave System can offer expedited healing rates in root canal therapy through improved cleaning, disinfection and preservation of natural tooth morphology. We are compelled to reference this data as we move toward broader commercialization of the GentleWave System and ultimately deliver on our mission of Saving Teeth Through Sound Science®.”

Bjarne Bergheim, the President and CEO of Sonendo, also stated, “Sonendo is committed to improving care for patients. We are therefore excited about this study: the GentleWave System enables improved healing and a cumulative success rate of 97.3%1. Over the past century, little has changed in root canal therapy. We are pleased that the GentleWave System is finally giving clinicians and their patients a better alternative than conventional root canal therapy.”

About Sonendo®
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science. The first commercially available product from Sonendo, the GentleWave System, available in the US, shows significant improvements in clinical efficacy, and treatment efficiency when compared to conventional root canal techniques2-3. For more information please visit:

1Sigurdsson A et al. J Endod. 2016; 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05. 3Haapasalo M et al. (2014) J Endod. 40:1178-81.

Forward-Looking Statements
This announcement contains forward-looking statements that are based on management's beliefs, assumptions and expectations and on information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.

Media Contact: Bob Guyatt Vice President of Marketing 949.766.3636

Source: Sonendo